Clinical trials
Active, not recruiting Phase 1 trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
112 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 2 |
| 2016 | 6 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 9 |
| 2020 | 9 |
| 2021 | 10 |
| 2022 | 21 |
| 2023 | 17 |
| 2024 | 24 |
| 2025 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 112 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 13 |
| AbbVie | 12 |
| Janssen Research & Development, LLC | 12 |
| Eli Lilly and Company | 9 |
| Boehringer Ingelheim | 8 |
| Amgen | 5 |
| AstraZeneca | 4 |
| GlaxoSmithKline | 3 |
| Incyte Corporation | 3 |
| Enliven Therapeutics | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 26 |
| Carcinoma, Non-Small-Cell Lung | 24 |
| Breast Neoplasms | 14 |
| Neoplasm Metastasis | 13 |
| Colorectal Neoplasms | 12 |
| Endometrial Neoplasms | 10 |
| Ovarian Neoplasms | 10 |
| Triple Negative Breast Neoplasms | 10 |
| Lung Neoplasms | 8 |
| Prostatic Neoplasms | 8 |
Trials
Showing 1 to 25 of 112. Each trial links to its page on Pharma Observatory.
12 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.